RadNet, Inc. (RDNT)
USD 50.37
(-0.3%)
USD 50.37
(-0.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 812.06 Million USD | -43.74% |
| 2022 | 1.44 Billion USD | 9.26% |
| 2021 | 1.32 Billion USD | 22.7% |
| 2020 | 1.07 Billion USD | -0.01% |
| 2019 | 1.07 Billion USD | 70.12% |
| 2018 | 633.01 Million USD | 10.08% |
| 2017 | 575.03 Million USD | -6.07% |
| 2016 | 612.17 Million USD | 0.75% |
| 2015 | 607.61 Million USD | 6.13% |
| 2014 | 572.5 Million USD | -0.51% |
| 2013 | 575.44 Million USD | 0.29% |
| 2012 | 573.76 Million USD | 5.2% |
| 2011 | 545.38 Million USD | 11.94% |
| 2010 | 487.21 Million USD | 13.24% |
| 2009 | 430.26 Million USD | -3.47% |
| 2008 | 445.71 Million USD | 9.03% |
| 2007 | 408.81 Million USD | 129.23% |
| 2006 | 178.34 Million USD | 649.06% |
| 2005 | 23.8 Million USD | -82.95% |
| 2004 | 139.65 Million USD | 15.72% |
| 2003 | 120.67 Million USD | -0.38% |
| 2002 | 121.13 Million USD | 11.95% |
| 2001 | 108.2 Million USD | 31.04% |
| 2000 | 82.57 Million USD | 6.54% |
| 1999 | 77.5 Million USD | -2.25% |
| 1998 | 79.28 Million USD | 3.17% |
| 1997 | 76.84 Million USD | -10.09% |
| 1996 | 85.46 Million USD | 58.01% |
| 1995 | 54.08 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 814.44 Million USD | 0.29% |
| 2024 Q2 | 1 Billion USD | 23.08% |
| 2023 Q1 | 1.47 Billion USD | 2.25% |
| 2023 FY | 812.06 Million USD | -43.74% |
| 2023 Q4 | 812.06 Million USD | -44.32% |
| 2023 Q2 | 1.47 Billion USD | 0.09% |
| 2023 Q3 | 1.45 Billion USD | -1.28% |
| 2022 Q4 | 1.44 Billion USD | 6.08% |
| 2022 FY | 1.44 Billion USD | 9.26% |
| 2022 Q3 | 1.36 Billion USD | -0.42% |
| 2022 Q2 | 1.36 Billion USD | 2.64% |
| 2022 Q1 | 1.33 Billion USD | 0.77% |
| 2021 FY | 1.32 Billion USD | 22.7% |
| 2021 Q4 | 1.32 Billion USD | 1.67% |
| 2021 Q3 | 1.29 Billion USD | -1.31% |
| 2021 Q1 | 1.1 Billion USD | 2.86% |
| 2021 Q2 | 1.31 Billion USD | 18.89% |
| 2020 Q2 | 1.06 Billion USD | -6.08% |
| 2020 FY | 1.07 Billion USD | -0.01% |
| 2020 Q1 | 1.12 Billion USD | 4.86% |
| 2020 Q4 | 1.07 Billion USD | 1.91% |
| 2020 Q3 | 1.05 Billion USD | -0.38% |
| 2019 Q1 | 1.01 Billion USD | 59.85% |
| 2019 FY | 1.07 Billion USD | 70.12% |
| 2019 Q2 | 1.08 Billion USD | 6.91% |
| 2019 Q3 | 1.07 Billion USD | -0.39% |
| 2019 Q4 | 1.07 Billion USD | -0.07% |
| 2018 Q4 | 633.01 Million USD | 14.48% |
| 2018 FY | 633.01 Million USD | 10.08% |
| 2018 Q1 | 569.64 Million USD | -0.94% |
| 2018 Q2 | 561.31 Million USD | -1.46% |
| 2018 Q3 | 552.96 Million USD | -1.49% |
| 2017 FY | 575.03 Million USD | -6.07% |
| 2017 Q4 | 575.03 Million USD | -1.38% |
| 2017 Q3 | 583.09 Million USD | -3.08% |
| 2017 Q2 | 601.65 Million USD | -1.05% |
| 2017 Q1 | 608.01 Million USD | -0.68% |
| 2016 Q3 | 620.3 Million USD | 2.08% |
| 2016 Q4 | 612.17 Million USD | -1.31% |
| 2016 Q2 | 607.68 Million USD | -1.45% |
| 2016 Q1 | 616.64 Million USD | 1.49% |
| 2016 FY | 612.17 Million USD | 0.75% |
| 2015 Q1 | 575.38 Million USD | 0.5% |
| 2015 Q2 | 616.72 Million USD | 7.19% |
| 2015 Q4 | 607.61 Million USD | -1.07% |
| 2015 FY | 607.61 Million USD | 6.13% |
| 2015 Q3 | 614.16 Million USD | -0.42% |
| 2014 Q3 | 588.59 Million USD | 0.17% |
| 2014 FY | 572.5 Million USD | -0.51% |
| 2014 Q4 | 572.5 Million USD | -2.73% |
| 2014 Q2 | 587.56 Million USD | -1.85% |
| 2014 Q1 | 598.63 Million USD | 4.03% |
| 2013 Q2 | 575.66 Million USD | 0.0% |
| 2013 Q4 | 575.44 Million USD | -0.27% |
| 2013 FY | 575.44 Million USD | 0.29% |
| 2013 Q1 | 575.64 Million USD | 0.33% |
| 2013 Q3 | 577 Million USD | 0.23% |
| 2012 FY | 573.76 Million USD | 5.2% |
| 2012 Q3 | 541.55 Million USD | -0.28% |
| 2012 Q2 | 543.04 Million USD | -0.46% |
| 2012 Q1 | 545.54 Million USD | 0.03% |
| 2012 Q4 | 573.76 Million USD | 5.95% |
| 2011 Q1 | 500.3 Million USD | 2.69% |
| 2011 Q3 | 512.04 Million USD | 0.68% |
| 2011 FY | 545.38 Million USD | 11.94% |
| 2011 Q4 | 545.38 Million USD | 6.51% |
| 2011 Q2 | 508.57 Million USD | 1.65% |
| 2010 Q2 | 490.56 Million USD | 15.66% |
| 2010 Q3 | 487.24 Million USD | -0.68% |
| 2010 FY | 487.21 Million USD | 13.24% |
| 2010 Q4 | 487.21 Million USD | -0.01% |
| 2010 Q1 | 424.13 Million USD | -1.42% |
| 2009 Q3 | 435.33 Million USD | -1.4% |
| 2009 Q4 | 430.26 Million USD | -1.16% |
| 2009 Q1 | 445.24 Million USD | -0.11% |
| 2009 Q2 | 441.5 Million USD | -0.84% |
| 2009 FY | 430.26 Million USD | -3.47% |
| 2008 Q2 | 460.02 Million USD | 0.07% |
| 2008 FY | 445.71 Million USD | 9.03% |
| 2008 Q3 | 460.27 Million USD | 0.05% |
| 2008 Q4 | 445.71 Million USD | -3.16% |
| 2008 Q1 | 459.69 Million USD | 12.45% |
| 2007 Q2 | 374.73 Million USD | 0.47% |
| 2007 Q1 | 372.96 Million USD | 0.0% |
| 2007 Q3 | 405.33 Million USD | 8.17% |
| 2007 Q4 | 408.81 Million USD | 0.86% |
| 2007 FY | 408.81 Million USD | 129.23% |
| 2006 Q3 | 178.34 Million USD | 3.86% |
| 2006 FY | 178.34 Million USD | 649.06% |
| 2006 Q2 | 171.72 Million USD | 2.97% |
| 2006 Q1 | 166.76 Million USD | 4.74% |
| 2005 Q3 | 23.8 Million USD | -82.45% |
| 2005 FY | 23.8 Million USD | -82.95% |
| 2005 Q4 | 159.22 Million USD | 568.75% |
| 2005 Q2 | 135.7 Million USD | -2.41% |
| 2005 Q1 | 139.06 Million USD | -1.17% |
| 2004 Q4 | 140.71 Million USD | 0.76% |
| 2004 Q1 | 112.53 Million USD | -6.05% |
| 2004 Q3 | 139.65 Million USD | -1.99% |
| 2004 Q2 | 142.48 Million USD | 26.61% |
| 2004 FY | 139.65 Million USD | 15.72% |
| 2003 Q2 | 111.28 Million USD | -10.01% |
| 2003 FY | 120.67 Million USD | -0.38% |
| 2003 Q3 | 120.67 Million USD | 8.43% |
| 2003 Q1 | 123.66 Million USD | 2.68% |
| 2003 Q4 | 119.78 Million USD | -0.74% |
| 2002 FY | 121.13 Million USD | 11.95% |
| 2002 Q4 | 120.43 Million USD | -0.58% |
| 2002 Q3 | 121.13 Million USD | -2.25% |
| 2002 Q2 | 123.91 Million USD | 0.43% |
| 2002 Q1 | 123.38 Million USD | 7.09% |
| 2001 Q1 | 88.09 Million USD | 3.56% |
| 2001 FY | 108.2 Million USD | 31.04% |
| 2001 Q4 | 115.21 Million USD | 6.48% |
| 2001 Q3 | 108.2 Million USD | 14.77% |
| 2001 Q2 | 94.27 Million USD | 7.02% |
| 2000 Q1 | 75.87 Million USD | -2.72% |
| 2000 Q4 | 85.06 Million USD | 3.02% |
| 2000 Q3 | 82.57 Million USD | -1.2% |
| 2000 Q2 | 83.57 Million USD | 10.15% |
| 2000 FY | 82.57 Million USD | 6.54% |
| 1999 Q1 | 79.8 Million USD | -1.85% |
| 1999 Q4 | 78 Million USD | 0.65% |
| 1999 FY | 77.5 Million USD | -2.25% |
| 1999 Q3 | 77.5 Million USD | -1.4% |
| 1999 Q2 | 78.6 Million USD | -1.5% |
| 1998 FY | 79.28 Million USD | 3.17% |
| 1998 Q3 | 77.4 Million USD | 10.73% |
| 1998 Q2 | 69.9 Million USD | 1.9% |
| 1998 Q1 | 68.6 Million USD | -4.59% |
| 1998 Q4 | 81.3 Million USD | 5.04% |
| 1997 Q1 | 77.6 Million USD | -7.73% |
| 1997 FY | 76.84 Million USD | -10.09% |
| 1997 Q4 | 71.9 Million USD | -3.36% |
| 1997 Q2 | 75.9 Million USD | -2.19% |
| 1997 Q3 | 74.4 Million USD | -1.98% |
| 1996 Q4 | 84.1 Million USD | 1.33% |
| 1996 Q3 | 83 Million USD | 18.4% |
| 1996 FY | 85.46 Million USD | 58.01% |
| 1996 Q2 | 70.1 Million USD | 1.01% |
| 1996 Q1 | 69.4 Million USD | 0.0% |
| 1995 FY | 54.08 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -26317.306% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -109763.332% |
| Aspira Women's Health Inc. | 1.43 Million USD | -56687.972% |
| Biodesix, Inc. | 35.22 Million USD | -2205.374% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -822139.098% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -72505.385% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -72505.385% |
| Bionano Genomics, Inc. | 7.17 Million USD | -11218.021% |
| CareDx, Inc | 28.27 Million USD | -2771.731% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 14.19 Million USD | -5619.594% |
| DarioHealth Corp. | 24.59 Million USD | -3202.298% |
| Exact Sciences Corporation | 2.47 Billion USD | 67.194% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -7931.53% |
| Guardant Health, Inc. | 1.13 Billion USD | 28.764% |
| ICON Public Limited Company | 3.66 Billion USD | 77.845% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -30.372% |
| Illumina, Inc. | 1.48 Billion USD | 45.462% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -998458.851% |
| iSpecimen Inc. | 29.13 Thousand USD | -2787637.727% |
| Standard BioTools Inc. | 3.98 Million USD | -20288.35% |
| MDxHealth SA | 35.56 Million USD | -2183.399% |
| 23andMe Holding Co. | 67.84 Million USD | -1096.946% |
| Medpace Holdings, Inc. | 142.12 Million USD | -471.388% |
| Myriad Genetics, Inc. | 130.9 Million USD | -520.373% |
| Mainz Biomed B.V. | 2.19 Million USD | -36881.286% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -422715.549% |
| NeoGenomics, Inc. | 606.06 Million USD | -33.989% |
| Neogen Corporation | 888.39 Million USD | 8.591% |
| Inotiv, Inc. | 399.4 Million USD | -103.317% |
| Natera, Inc. | 282.94 Million USD | -187.006% |
| OpGen, Inc. | 2.02 Million USD | -40069.251% |
| OPKO Health, Inc. | 222.03 Million USD | -265.74% |
| Psychemedics Corporation | 945 Thousand USD | -85833.122% |
| Prenetics Global Limited | 867.21 Thousand USD | -93540.908% |
| Prenetics Global Limited | 867.21 Thousand USD | -93540.908% |
| Precipio, Inc. | 106 Thousand USD | -766001.887% |
| Personalis, Inc. | 1.23 Million USD | -65707.78% |
| Sera Prognostics, Inc. | 840 Thousand USD | -96574.762% |
| Sotera Health Company | 2.22 Billion USD | 63.481% |
| Neuronetics, Inc. | 59.28 Million USD | -1269.816% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -70822.969% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -70822.969% |
| Trinity Biotech plc | 54.65 Million USD | -1385.916% |
| T2 Biosystems, Inc. | 6.59 Million USD | -12207.79% |
| Twist Bioscience Corporation | 79.17 Million USD | -925.688% |
| Exagen Inc. | 19.23 Million USD | -4122.703% |